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Summary
Although some studies of pre-emptive analgesia have
reported small reductions in post-operative pain or
analgesic consumption in favour ofpre-incislonal vs. post-
inclslonalor post-operative treatment, most have not
demonstrated any benefit at all. This paper reviews recent
evidence supporting the effectiveness of pre-emptive
analgesia and discusses factors that may be responsible
for the lack of consistent results. These factors include
problems with the accepted definition of pre-emptive
analgesia, the potential pre-emptive analgesic effects of
other agents (e.g. oplolds, nitrous oxide, pentobarbitone)
used routinely as part of the general anaesthetic, the role
of post-operative Inflammationin Initiating and enhancing
Introduction
The field of pre-emptive analgesia has developeddirectly
from basic science research carried out over the past dec-
ade [1-3]. Studies demonstrate that administration of
oploids or local anaesthetics before noxious stimulation
prevents development of injury-induced spinal
hyperexcitability and pain-related behaviour. By contrast,
the same treatments are significantly less effective when
administered only minutes later, after the' prolonged cen-
tratex,cltBbIUty or pain behaviours have been established.
The editorial in Pain by Wall [4] and the accompanying
paper by McQuay et al. [5] provided the Impetus for con-
trolled studies of pre-emptive analgesia In patients sched-
uled for surgery.
Although initial studies of pre-emptive analgesia showed
that pre-operative blockade with local anaesthetics or pre-
operative administration of systemic oplolds was more ef-
a state of central sensitlzatlon, and the lack of a true
placebo control condition. Given the constraints of clinical
research and current standards of practice, it is unlikely
that studies of pre-emptive analgesia using conventional
analgesics or local anaesthetics will yield large reductions
In post-operative pain or analgesic consumption. Extending
tlie pre-emptive treatment well into the post-operative
period using balanced, multimodal analgesia, may prolong
the Initial advantage conferred by the pre-operative
blockade and possibly interfere with the development of
long-lasting pain.
Keywords: ANALGESIA, pre-emptive; PAIN; plasticity; COM·
PLICATIONS, Inflammation.
fective in re(fucing post-operative pain. than control condi-
tions InvolVing no treatment (Fig. 1a), the results of sub-
sequent investigations comparing the effects of
preoperatlve treatment with the same treatment initiated
after Incision orsurgery (Fig. 1b,c) ,have producedincon-
sistent results (see [6-9] for recent reviews). The reasons
. for the lack of consistency are not clear. This pap,r will
examine some of the possible factors that have contrib-
uted to the Inconsistent results.
Studies shOWing that post-operative pain can be pre-
empted have generally found small, albeit significant, re-
ductions In pain and/orpost-operative analgesic consump-
tion. For example, pain intensity 72 h after lower abdomi-
nal surgery is rated as mild in both pre- and post-treated
groups, but it Is even milder in the pre-treated group {1 0].
Typical reductions In morphine consumption amount to
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'1O.1.Va'rlou8-deslgnsused to evaluatetheeffeetlveness ofpre"emptlve analgesia showing the expected outcomes In terms of
pclst;.operaUIJepalnandanalgesle·consumptlon.(a)lriltlal8tudlescomparedan active agent with a placebo control condition or a
n~tr..~ntconb:olcondlt~.(b-c)Larerstudies examined the effectiveness of apre-Inclslonal condition with a post-Inclsional or
post"Surglcal~UOn. (d)Compari$onof.a·pre-lnclslonal andpolt-lncislonalG:l)ndltlon With a post-Inclslonal condition In an attempt
.t01aotate ttfe;~ of Indalori and subsequent noxlou$perl-operatlve eventS on post-operative pain. (e-f) Recommended designs
for future 8tUdl68 ofp~t1veanalg~la.Seetextfor details.' '. . ..
approximat8ly250/0 over a 24-hperiod, but the absolute
.·Qlfferenee (8.:g; 10"';16 mg) b&tween pre- ahd post~treated
gtoupsfs actuaRy very small [1'0-12]. The magnitude of
these &ffectssuggesrs that the contribution of sensitized
centridneuroneSto the total post-operative pain experi·
ence maybe overshadoWed by the more salient 'periph·
eral' hi'pur [13].
'CUnlcal8lgnlflcance
A frequent· criticism of'these studies has 'been the lack of
cllnlctilly slgnificant:effectfi. However, it is not a simple
matter to define '8 clinically significant reduction In pain or
analgesic consumption. This1s in part because clinical sig-
nificance 18 not on1ya function of effect size but of quality
(of pain anGlpain relief) and in part because pain is a sub-
jectlv8 experience. The clinical slgnlficanceofa reduction
in pain -or.analgeslc consumption shoUld be evaluated first
and foremost from the patient's perspective. This Is par-
ticularly true ·of studies in which patients are in control of
their post-op&ratlve analgesic consumption. ·Moreover
since post-operative pain Is not adequately oontrolled for
most patients, any decrease in pain and ana'gesic con-
sumption without added risk is to be welcomed.
Rol. of oth.r .g.nts In p.....mptlng post-
op.ratlv.paln
Perhaps a more valid criticism of some of these studies
(e.g~ [10,11]) Is their lack of a clinically f6levantgeneral
anaesthetic regimen since In an effort to evaluate the pre-
. emptlve effects of epidural analgesia or anaesthesia,
oplolds deliberately are not administered pre- or intra-
operatively. It Is not known whether post-operative pain
would be pre-empted to the same degree by pre- vs. post-
incls/onal administration of these agents If patients also
.received an oplold preomedlcatlon and/or opiolds peri-
. operatively. Although there Is evidence both for [12J and
aQ8lnst [14J the ability of systemic opioids to pre-empt post-
operative pain when used as the target pre-emptlv. agent,
It is likely that they contribute to a pre-emptive effect when
administered Instudies designed to assess the pre-emptive
effects of. local anaesthetics or oploids delivered by other
routes. This would have the unintended effect of pre-
emptlng pain In both pre-Incislonal and post-surgical
treatment groups and thus contribute to non-significant
Inter-group differences In post-operative paJn and
analgesic consumption. .
Similarly, It Is possible that other agents administered
as part of the general anaesthetic regimen, also have sub-
tle, additive pre-emptive effects, which may attenuate the
central sensitizing effects of surgery In all patients. In this
context, the difference between the degree of attenuation
of central sensltlzatlon achieved by the target treatment
(e.g. local anaesthetic infiltrations, nerve blocks, epidural
or splnally administered anaesthetics or oplolds) given
before vs; after surgery, over and above that produced by
the other agents, may make It difficult to detect significant
differences In post~operative pain or analgesic consump-
tion. '
Although comparable data from the clinical setting are
not available; recent studies of pre-emptive analgesia us-
Ing the r_t formalin model have shown that nitrous oxide
[15J and pentobarbitone [16J each can pre-empt second-
phase nociceptive responses. There Is also evidence from
a more clinically relevant animal model to support the hy~
pothssls that morphine and pentobarbitone may produce
sub~le pre-emptive analgesic effects which dilute the po-
tential effect· of a target pre-emptive treatment [17]. Rats
that received I.v.pentobarbitone, I.v. morphine, and I.t.
buplvacalne prior to intra-articular formalin Injection had
significantly reduced nociceptive responses when com-
pared to a saline control group, but not to a group that
received I.v. pentobarbitone and i.v. morphine prior to in-
jury and post-Injury Intrathecal buplvacalne. Moreover, al-
though rats given I.v. pentobarbitone, i.v. morphine, ·and
I.t. saline prior to injUry showed lower nociceptive scores
compared with the saline control group, these groups did
not differ significantly. Thus, while the pentobarbitone and
morphine did not reduce nociceptive behavlo~rslgnlficantiy
compared to the control group these agents may have low-
ered nociceptive responses sufficiently to contribute to the
lack of significance between rats treated with l. t.
bupivacaine before.vs. after Injury.
D.slgn Issu.s
Use of the term pre-emptive analgesia to refer exclusively
to evidence that pre-operative treatment is more effective
than post-operative treatment (as opposed to no treatment
ora placebo treatment) may be too restrictive and narrow.
It has been argued that evidence of pre-emptive analgesia
requires control of the same intervention made after
surgery but in doing so, it may not be possible, or even
.desirable, to ensure that the groups are. treated similarly
with respect to otheranaesthetic agents. For example, end~
tidal Isotlurane was significantly lower over the 60-min
interval after skin incision· among patients that received
lumbarepidural bupivacaine before vs. 30 min after incision
[10J. We do not know whether this Inter-group difference
contributed to the reduced post-operative pain and
. .
analgesic consumption observed among the pre-incisional
treatment group. As noted above, it Is possible that other
agents administered during surgery may contribute directly
or Indirectly to a pre-emptive effect. A good example of
this Is the finding that halothane antagonizes the pre-
emptlve effect of nitrous oxide In the rat formalin model
[15]. Thus, because of the clinical n~ture of the research,
ensuring that the two groups are treated the same with
respect to the target pre-emptive treatment may mean
treating themdifferently in other potentially Important ways.
Demonstrating that pre-treatment with analge~ics, but
not a placebo, lessens pain and decreases post-opera-
tive analgesic reqUirements at a time when the agents are
no longer clinically active, suggests that the central com-
ponent of post-operative pain can be prevented or pre-
empted. In the absence of apost-Inclsional or post-opera-
tive control condition, it is notpossible to determine whether
factors associated with the Intra-operative or post-opera-
tive period (or both) are necessary for the enhanced post-
operative pain experience. Altering the timing of adminis-
.,,'
tration ,(Fig. 1b-d) may provide clues to the specific
IlitiaOpetatlve (e.g. InCision, wound retraction) or post-op-
eratIVe (e.". inflammation). factors that contribute to the
centrat neullBl changes underlying the enhanced pain.
Nevertheless, In the absence of a post-treatment condi-
tion, the finding ,that pain or analgesic consumption is re-
duced'relatlve to an untreated control condition (Fig. 1a)
after'thectinlcal· duration of 'action of the putative pre-
emptive agent is evidence ·of a pre-emptive analgesic ef-
fect: such a design, however; does not provide informa-
tion about the possible mechanism(s) underlying the pre-
emptive effect. The use of incomplete designs that con-
sist of apost-Incisional or post-surgical condition (Fig. 1b-
d) without atrue placebo condition (Fig. 1e, f) may In part
be responsible for the small effects of pre-emptive anal-
gesi~. Use of 'designs shown in Fig. 1 (e, f) may extend
the focus of attention from pre-empting the effects of nox-
ious intra-operative,events to that of post-operative inflam-
mation.
and post-Incisional groups (FJg. 2) even though McGiII Pain
Questionnaire scores were higher In the post-incisional
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Fig. 2. Post-operative cumulative pallent-controlled morphine
consumption from (a) 12-24 hand (bl24-72 h after surgery for
patients that received lumbar epidural buplvacalne (15 ml
0.5%) approximately 40,mln before Incision (Group 1 PRE) or
30 mln after incision (Group 2 POST), showing best-fitting least
squares lines relating morphine consumption to time after
surgery. The greatest divergenCe In the hourly rate of morphine
consumption occurred within the second 12-h period after
surgery with groups 1and 2self-administering approximately
1.7 mg h" and 2.9 mg h"respectively (al while from 24 h
onward, the slopes of the least squares straight lines were
virtually parallel (b). Data from Katz et 81.(10)* P < 0.04.
y= 25.7 + 1.3x R2= 0.99
Post-operative Inflammation
It has been suggested that failure to demonstr,atea, pre~
emptive analgesic effect may reflect an inflammation~in­
d\.lced state of central sensitizatlon that develops after the
pharmacological setion of the pre~operative agent has dis-
appeared or.in·th,e case of continuous epidural infusion
due to Insufficient afferent blockade In tl)9 post-operative
period.PartlaJ support for the possibility that post-opera-
tive inflammatory'inputs from the wound may initiate a state
of ~ntral sensltltati6n has been reported in a three-group
study that evaluated the effects of 10 mg morphine i.m.
administered either 1 h before surgery, t.v. at the time of
induction, or i.v. at the time of wound closure [12]. Twenty-
four hoursafter surgery, patient-controlled morphine con-
sumptioh wBlsIgnlficantlylower in the group pre-treated
with i.v. mcrphinecompared with the group treated at the
time of'wound closure. However, movement-associated
pain scores 48 h after surgery were higher in' the i.v. pre-
treated group, suggesting that the' extra morphine used
by patients in the i.v. post group during the first 24 h after
surgerY pre-empted pain In the second 24-h period.
The results ota stUdy by Katzet al. [10] do not show
this trend. Twenty.four and 48 h after surgery, cumulative
peA morphine consumption was significantly lower in pa-
tientsthat received epidural bupivacaine before vs. 30 min
after incision, but the iate of morphine'consumption from
24 hafter surgery onward was virtually identical In the pre-
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group 72 h after surgery. These results do not support the
suggestion (a) that a state of central sensitization which
may have developed after surgery in the pre-Inclslonal
group (group '1 ) was sufficient to overcome the pre-emptive
effect relative to the post-Inclsional group (group 2), or (b)
thatthe additional morphine used by group 21n the first 48
h was sufficient to pre-empt sUbsequent pain relative to
group 1. The results suggest that the central sensitlzation
triggered by the'initial injury barrage during lower abdomi-
nal surgeryand the central sensltizatlon that develops over
the 72 h after surgery due to ongoing peripheral Inflam-
mation make separate contributions to the experience of
. post-operative pain [13).,The Inflammatory inputs In the
post-operative period appear to Initiate (in the pre-incisional
group) and enhance (in the post-Inclslonal group) a state
of central sensitization so that pain is amplified leading to
additional.morphine reqUirements among patients who
received the active treatment after Incision compared with
the pre-treated patients.
Another possibility is that the development of post-op-
erative Inflammation may be attenuated at the level of the
spinal cord by a central neural mechanism follOWing pre-
emptive epidural or spinal local anaesthesia. Recent ani-
mal stUdies show that joint inflammation In an experimen-
tal model of arthritis Is significantly reduced following spi-
nal administration of the non-NMDA antagonist CNQX [18).
Thus It may be that pre.lnclslonal spinal local anaesthesia
pre-empts pain by more than one mecJ1anism. In addition
to attenuating the effects of the afferent barrage associ-
ated with surgery, It Is possible that the degree of periph-
eral inflammation may also be reduced. When this Is con-
sl~red In conjunction with the finding that inflammation
associated with Injection of carrageenan Into a rat's paw
induces a 3Q-fold Increase In the potency of morphine to
Inhibit C-fibre-evoked responses In dorsal hom neurones
[19], it raises questions about the Interpretation of (nega-
tive) findings from certain clinical studies of pre-emptive
analgesia. The E050 for inhibiting the Cofibre-evoked re-
sponse In normal animals was 9.17 pg of morphine. Fol-
lOWing the induction of periphe~al inflammatloii the ED50
dropped to 0.28 pg of morphine.
While extrapolation from animal studies to the clinical
setting is rarely justified; it is nonetheless interesting to
speculate on the meaning of a non-significant difference
in pain or morphine consumption if sim,ilar mechanisms
were operative In humans. If development of inflamma-
tion is attenuated bypre-emptive spinal local anaesthesia
and If the potency of morphine Increases In the presence
of peripheral Inflammation, then cQmpared with apre-
treated group, untreated patients or patients treated after
incision or surgery would be expected to de~elop agreater
d$gree of Inflammation and pain, but would not require
more morphine post-operatively to reduce their pain to a
comparable intensity. It Is not inconcelvalSle that the pat-
tem of pain scores and analgesic consumption would be
similar in the pre- and post-treated groups even though
patients may have benefited to a greater degree from the
pre-treatment. The typical stUdy of pre-emptive analgesia
in which patients control their post-operative opioidcon-
sumption would not detect such a benefit. Keeping anal-
gesic consumption fixed while looking for inter-group dif·
ferences In pain intensity would, in general, provide amore
direct test of the predictions of pre-emptive analgesia;
namely, less pain when resting and mOVing about.
Long-term effects of pre-emptive analgesia
Given the small benefits observed In some studies shortly
after surgery, it should come as no surprise that longer-
term effects have not been found, either in the incidence
or Intensity of chronic chest wall pain 2 years after
thoracotomy, or post-inclsional pain 9 months after lower
abdominal surgery [20).The most striking finding is that
the incidence of chronic post-thoracotomy pain is unac-
ceptably high (approximately 60%) whether patients re-
ceived pre-emptive or post-Inclslonal epidural fentanyl
dUring surgery. These results suggest that although some
pre-emptive treatments may reduce pain and analgesic
consumption in the early days aftersurgery, the short-term
benefits have no.bearing·on the development of chronic
post-thoracotomy pain. Extending the pre-emptive treat-
ment well into the post-operative recov.ery period, using
balanced, multi-modal analgesia [21], may prolong the
Initial advantage conferred by the pre-operative blockade
and possibly interfere with the development of long-last-
ingpaln.
Conclusions
The constraints of clinical research and current standards
of practice make it unlikely that studies of pre-emptive
analgesia using conventional analgesics or local
anaesthetics will yield large reductions in post-operative
pain or analgesic consumption. The difficulties in
demonstrating that post-operative pain can be pre-empted
reflect problems in the definition of pre-emptive analgesia,
"the ccinfQUt1dlngeff~cts of other agents used during ge~eral
anaesthesia, the role of post-operative inflammation, and
methodological factors· (use of PCA to indirectly measure
pain and incomplete control conditions). Future studies
using agents that block the NMDA receptor may prove
helpful in preventing acute postoperative pain from
becoming chronic.
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